• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

3-Hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5): A Comprehensive Overview of Its Chemical Properties and Biomedical Applications

3-Hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This molecule, characterized by its unique hydrazinyl and methoxy functional groups, exhibits a range of chemical and biological properties that make it a valuable scaffold for drug discovery. The pyridine ring system, a common structural motif in numerous bioactive compounds, provides the compound with inherent stability and reactivity, enabling its integration into diverse molecular frameworks. Recent studies have highlighted the potential of 3-hydrazinyl-2-methoxypyridine as a precursor for the synthesis of hydrazine derivatives with applications in antitumor, antiviral, and anti-inflammatory therapies. Its methoxy substituent, in particular, has been shown to enhance solubility and modulate electronic properties, which are critical for optimizing pharmacokinetic profiles in drug development.

The chemical structure of 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) is defined by a six-membered pyridine ring with a hydrazine group at the 3-position and a methoxy group at the 2-position. This arrangement confers the molecule with a planar geometry that facilitates π-π stacking interactions, a property that is often exploited in the design of molecular sensors and nanomaterials. Spectroscopic analyses, including nuclear magnetic resonance (NMR) and infrared (IR) spectroscopy, have confirmed the presence of characteristic absorption bands corresponding to the hydrazine NH₂ groups and the methoxy OCH₃ substituent. The hydrazinyl functionality, known for its nucleophilic character, has been leveraged in recent research to develop hydrazone-based compounds with enhanced bioavailability and targeting specificity. For instance, a 2023 study published in Journal of Medicinal Chemistry demonstrated that derivatives of 3-hydrazinyl-2-methoxypyridine could be functionalized with peptidomimetic moieties to improve their affinity for protease targets involved in cancer progression.

Recent advances in medicinal chemistry have underscored the role of 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) as a key intermediate in the synthesis of hydrazine-derived drugs with diverse therapeutic applications. The hydrazinyl group serves as a versatile handle for further chemical modifications, enabling the creation of hydrazone prodrugs that are activated under specific physiological conditions. A notable example is the development of hydrazine-based antitubercular agents, where the methoxy substituent was found to enhance the metabolic stability of the compound in in vitro models. In a 2022 study conducted by researchers at the Indian Institute of Science, 3-hydrazinyl-2-methoxypyridine was conjugated with fluorinated aromatic rings to create fluorinated hydrazine derivatives that exhibited potent inhibitory activity against Mycobacterium tuberculosis. These findings have sparked interest in exploring the fluorination strategy as a means to improve the lipophilicity and bioavailability of hydrazine-based drugs.

The hydrazinyl functionality in 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) also plays a critical role in the formation of azo compounds, which are widely used in dye chemistry and as nitroso reagents in organic synthesis. Azo derivatives of this molecule have been investigated for their potential as photochromic materials, which can undergo reversible structural changes upon exposure to light. In a groundbreaking study published in Advanced Materials (2024), scientists demonstrated that azo derivatives of 3-hydrazinyl-2-methoxypyridine could be incorporated into polymer matrices to create smart windows that modulate light transmission in response to environmental stimuli. This application highlights the molecule’s versatility beyond traditional pharmaceutical contexts, extending into materials science and nanotechnology.

Despite its promising applications, the hydrazinyl group in 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) presents unique challenges in terms of stability and reactivity. The hydrazine moiety is known to be susceptible to oxidative degradation, which can limit the shelf life of compounds containing this functionality. To address this, recent research has focused on the encapsulation of hydrazine derivatives within polymeric nanoparticles to enhance their chemical stability and targeted delivery to specific tissues. A 2023 paper in Nano Letters reported that polymeric micelles functionalized with 3-hydrazinyl-2-methoxypyridine derivatives demonstrated improved in vivo efficacy in antitumor therapies due to their ability to evade immune recognition and accumulate in hypoxic tumor regions.

In the realm of bioorganic chemistry, 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) has been employed as a ligand in the synthesis of transition metal complexes with potential applications in catalysis and antimicrobial agents. The methoxy group has been shown to act as a chelating agent, forming stable complexes with transition metals such as zinc and copper. These complexes have been tested for their antimicrobial activity against Methicillin-resistant Staphylococcus aureus (MRSA), with some derivatives exhibiting minimum inhibitory concentrations (MICs) as low as 5 μM. The hydrazinyl group, in this context, was found to enhance the electronic conductivity of the complexes, a property that is beneficial for electrochemical applications.

The methoxy substituent in 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) has also been explored for its bioisosteric replacement potential in drug design. By substituting the methoxy group with other oxygen-containing moieties, researchers have been able to modulate the pharmacokinetic properties of hydrazine derivatives. For instance, replacing the methoxy group with a hydroxyl group resulted in compounds with enhanced solubility and improved metabolic stability. These findings underscore the importance of structure-activity relationship (SAR) studies in optimizing the therapeutic potential of hydrazine-based molecules.

As the field of hydrazine chemistry continues to evolve, 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) stands out as a versatile molecule with multifaceted applications. From its role in pharmaceutical development to its use in advanced materials, this compound exemplifies the interdisciplinary nature of modern chemical research. Future studies are likely to focus on computational modeling to predict the reactivity patterns of hydrazine derivatives and on green synthesis methods to reduce the environmental impact of their production.

The compound 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) is a multifunctional molecule with a wide range of applications across pharmaceuticals, materials science, and bioorganic chemistry. Below is a concise summary of its key properties and applications, structured into clear sections for clarity: --- ### 1. Chemical Structure and Properties - Core Structure: A pyridine ring substituted with a hydrazinyl group at the 3-position and a methoxy group at the 2-position. - Reactivity: The hydrazine group is highly reactive, enabling participation in azo coupling, oxidative degradation, and coordination with transition metals. - Stability: The methoxy group enhances chemical stability and solubility, but the hydrazine moiety remains susceptible to oxidation. --- ### 2. Pharmaceutical Applications - Antimicrobial Activity: Transition metal complexes derived from this compound show potent activity against MRSA. - Antitumor Therapies: Encapsulated derivatives in polymeric nanoparticles improve targeted drug delivery and in vivo efficacy. - Drug Design: Structure-activity relationship (SAR) studies have shown that modifying the methoxy group can enhance solubility and metabolic stability. --- ### 3. Materials Science - Photochromic Materials: Azo derivatives of this compound are used in smart windows that modulate light transmission. - Polymer Matrices: Incorporation into polymer matrices enables stimuli-responsive materials with potential in optoelectronics. --- ### 4. Bioorganic and Catalytic Applications - Metal Complexes: The compound acts as a ligand in transition metal complexes, with applications in catalysis and electrochemistry. - Antimicrobial Agents: Certain complexes exhibit low MICs against MRSA, highlighting their therapeutic potential. --- ### 5. Challenges and Future Directions - Stability Issues: The hydrazine group requires stabilization strategies (e.g., encapsulation) to mitigate oxidative degradation. - Green Chemistry: Focus on sustainable synthesis methods to reduce environmental impact. - Computational Modeling: Predicting reactivity patterns and optimizing molecular design for targeted applications. --- ### Conclusion 3-hydrazinyl-2-methoxypyridine (CAS No. 160590-38-5) is a versatile scaffold with interdisciplinary applications. Its reactive hydrazine group and stabilizing methoxy substituent make it a valuable molecule for drug development, materials engineering, and catalysis. Continued research into its chemical modifications and biological interactions will likely expand its therapeutic and technological potential in the future.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)